2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation
US5925624A · kind A · utility
6Cited by
12References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 1995 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | Sep 18, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/167
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 2,6-diaminopurine-.beta.-D-ribofuranuronamide derivatives of the following formula (I). These compounds and their salts and solvates are useful as anti-inflammatory agents, particularly in the treatment of patients with inflammatory conditions who are susceptible to leukocyte-induced tissue damage. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.